venBio Select Advisor »

Alkermes shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-09-30 $67M 2.2M 30.00
2025-06-30 $83M 2.9M 28.61
2025-03-31 $81M 2.5M 33.02
2024-12-31 $71M 2.5M 28.76

More positions owned by venBio Select Advisor

Ascendis Pharma Sponsored ADR (ASND)
United Therapeutics Corp Common (UTHR)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Merus N V Common (MRUS)
Avidity Biosciences Common (RNA)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Adr (CNTA)
Uniqure Nv Common (QURE)
Xenon Pharmaceuticals Common (XENE)
Akero Therapeutics Common (AKRO)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Alkermes

BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Renaissance Technologies
American Century Companies
Geode Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Commodore Capital
PRIMECAP Management Company
Holocene Advisors
venBio Select Advisor
Nuveen
Charles Schwab Investment Management

View all funds holding Alkermes